Aehr Test Systems provides earnings guidance for the fiscal year ending May 31, 2024. For the period, the company reiterating its previously provided guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.46 USD | +2.90% | -4.78% | -61.70% |
04-10 | Sector Update: Tech Stocks Decline Premarket Wednesday | MT |
04-10 | Aehr Swings to Fiscal Q3 Non-GAAP Loss, Revenue Drops; Shares Decline Premarket | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-61.70% | 294M | |
+41.24% | 397B | |
+37.83% | 138B | |
+37.79% | 102B | |
+27.78% | 22.85B | |
+11.67% | 20.09B | |
+43.52% | 10.62B | |
+17.42% | 9.62B | |
+20.66% | 9.22B | |
+46.85% | 5.49B |
- Stock Market
- Equities
- AEHR Stock
- News Aehr Test Systems
- Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024